STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

CLSD CLEARSIDE BIOMEDICAL INCORPORATED StockScouter® Report

6

StockScouter® Score

CLEARSIDE BIOMEDICAL INCORPORATED, a micro cap growth company in the healthcare sector, is expected to perform in line with the market over the next six months with slightly higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • Moving average analysis for CLSD suggests strong price movement over the medium term. Positive
  • An executive, director or major shareholder purchased a large number of shares recently. Postive/Neutral

 

Concerns

  • The enterprise value-to-sales ratio is much higher than the average for comparably-sized companies in the StockScouter universe. Very Negative
  • Earnings growth in the past year has decelerated rapidly compared to earnings growth in the past three years. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be neutral, growth stocks will be neutral, and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 80% done.
Progress: 60% done.
Low
High

Core Model Grades

D
A
F
C

Previous Ratings

4
6
3